152 related articles for article (PubMed ID: 37522480)
1. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.
Bucciol R; Othman M
Curr Opin Hematol; 2023 Sep; 30(5):180-185. PubMed ID: 37522480
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
4. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
5. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
Ye R; Ye C; Huang Y; Liu L; Wang S
Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
[TBL] [Abstract][Full Text] [Related]
6. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
8. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
Tesselaar ME; Romijn FP; Van Der Linden IK; Prins FA; Bertina RM; Osanto S
J Thromb Haemost; 2007 Mar; 5(3):520-7. PubMed ID: 17166244
[TBL] [Abstract][Full Text] [Related]
9. Tumour and microparticle tissue factor expression and cancer thrombosis.
Date K; Hall J; Greenman J; Maraveyas A; Madden LA
Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
11. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles as risk markers for venous thrombosis.
Rautou PE; Mackman N
Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
[TBL] [Abstract][Full Text] [Related]
13. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
14. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
15. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
17. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.
Zwicker JI
Thromb Res; 2010 Apr; 125 Suppl 2():S89-91. PubMed ID: 20434015
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
20. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
